* . * . . .
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Cookie Privacy Policy
  • DMCA
  • California Consumer Privacy Act (CCPA)
Thursday, August 7, 2025
Love Europe
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
  • Sports
  • Travel
No Result
View All Result
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
  • Sports
  • Travel
No Result
View All Result
Love Europe
No Result
View All Result
Home Spain

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

October 9, 2024
in Spain
Share on FacebookShare on Twitter
ADVERTISEMENT

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241008530546/en/

Avania, the leading, global medical technology contract research organization and advisory services partner, announces its acquisition of Anagram. (Graphic: Business Wire)

Avania, the leading, global medical technology contract research organization and advisory services partner, announces its acquisition of Anagram. (Graphic: Business Wire)

Founded in 1998, Anagram delivers a full service CRO model to their customers including diagnostic imaging core lab (centralized quality control and central assessment of images in clinical trials) services. It is focused on cardiology, oncology, and neurology therapeutic areas. They conduct studies in the U.S., U.K., Spain, Netherlands, France, Germany, and more.

Anagram is a perfect fit for Avania, enabling the company to increase CRO business in Spain and providing greater access to a growing MedTech country. The addition will support cross-sell opportunity by adding scale and will eliminate reliance on current outsourcing partners. Avania customers will benefit from an expanded geographic footprint and an enhanced roster of subject matter experts concentrated on areas of key therapeutic expertise.

“The addition of Anagram furthers our vision of becoming a trusted global partner for the MedTech community, advancing innovations from bench to bedside and improving patient outcomes globally,” said Jason Monteleone, president and CEO of Avania. “It will provide us with a significant footprint in Spain and Southern Europe and further strengthen our cardiovascular and neurology franchises while expanding our oncology capabilities.”

About Avania

Avania is the leading global MedTech clinical research organization and advisory partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. When you need to advance your medical technology, It Takes Avania.

About Anagram

Anagram is a Clinical Research Organization (CRO) based in Spain providing high quality services in clinical development and post-authorization trials for drugs and medical devices. Services include image central reading (core lab), analysis, and reporting by highly experienced professionals. Anagram has specialized expertise in cardiology, neurology, and oncology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241008530546/en/

Holli Kroeker

+1 308 338 2358

[email protected]

Jasmine Saba

+1 214 418 3201

[email protected]

 

© Business Wire, Inc.

Disclaimer:
This press release is not a document produced by AFP. AFP shall not bear responsibility for its content. In case you have any questions about this press release, please refer to the contact person/entity mentioned in the text of the press release.

Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6705d6c53970473dab78103f3ea9f6df&url=https%3A%2F%2Fwww.afp.com%2Fen%2Fnews%2F1313%2Favania-buys-spanish-medtech-cro-anagram-enhance-its-core-cro-offering-new-european-geography-202410085305461&c=14342375876562836927&mkt=de-de

Author :

Publish date : 2024-10-08 07:10:00

Copyright for syndicated content belongs to the linked Source.

Tags: EuropeSpain
ADVERTISEMENT
Previous Post

LinkedIn to train AI model with users’ data, excluding Switzerland, UK, and European data 

Next Post

Udinese Technical Director Denies Inter Milan Approach For Slovenia EURO 2024 Star

Related Posts

Spain

Singapore’s GIC Acquires 25% Stake in Spain’s Broadband Venture

Spain

England vs Spain LIVE: Women’s Rugby Union score, lineups, kick-off time & updates – BBC

Spain

England beats Spain on penalties to win Women’s Euro 2025 final – CNN

ADVERTISEMENT

Highlights

North Macedonia Must Close the Gap Between Promises and Reality on Roma Rights and Environmental Protection

Explore The Best Of Italy, Slovenia, And Croatia With New Deal Europe’s New Campaign For North American Travel Advisors – Travel And Tour World

Montenegrin Banks’ H1 Net Profit Drops 20% Year-on-Year

The Netherlands Makes History as the First Country to Purchase US Arms for Ukraine

Albanian Politicians in North Macedonia Condemn Kumanovo Scandal as a Blow to Citizenship and Sportsmanship

Categories

Archives

October 2024
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Sep   Nov »
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Cookie Privacy Policy
  • DMCA
  • California Consumer Privacy Act (CCPA)
No Result
View All Result
  • Home
  • Politics
  • News
  • Business
  • Culture
  • Sports
  • Lifestyle
  • Travel
  • Opinion

© 2024 Love-Europe

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version